2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
---|---|---|---|---|
营业收入(元) | ||||
骨疏康(元) | 187,235,810.39 | 95,390,179.15 | 199,230,173.53 | 103,410,201.23 |
荷丹片(元) | 109,019,939.57 | 61,803,565.92 | 122,088,950.22 | 60,048,784.66 |
脑血疏口服液(元) | 117,425,938.72 | 71,218,292.04 | 134,301,477.12 | 70,524,267.55 |
心可舒片(元) | 405,525,862.79 | 221,092,502.28 | 476,991,689.24 | 230,296,193.77 |
其他主营业务(元) | - | - | - | 39,317,586.97 |
其他(元) | 90,299,220.25 | 42,804,568.26 | 82,206,165.39 | 39,317,586.97 |
营业成本(元) | ||||
骨疏康(元) | 90,691,764.05 | 47,583,788.34 | 90,544,308.46 | 44,994,685.02 |
荷丹片(元) | 19,806,388.83 | 10,931,352.42 | 23,477,578.52 | 11,694,576.86 |
脑血疏口服液(元) | 27,402,959.04 | 16,361,923.10 | 30,050,850.12 | 15,594,934.70 |
心可舒片(元) | 54,409,581.57 | 26,473,322.36 | 70,047,589.99 | 35,809,865.61 |
其他主营业务(元) | - | - | - | - |
其他(元) | 40,126,709.77 | 18,635,177.21 | 36,764,111.86 | - |
毛利(元) | ||||
骨疏康(元) | 96,544,046.34 | 47,806,390.81 | 108,685,865.07 | 58,415,516.21 |
荷丹片(元) | 89,213,550.74 | 50,872,213.50 | 98,611,371.70 | 48,354,207.80 |
脑血疏口服液(元) | 90,022,979.68 | 54,856,368.94 | 104,250,627.00 | 54,929,332.85 |
心可舒片(元) | 351,116,281.22 | 194,619,179.92 | 406,944,099.25 | 194,486,328.16 |
其他主营业务(元) | - | - | - | - |
其他(元) | 50,172,510.48 | 24,169,391.05 | 45,442,053.53 | - |
毛利率(%) | ||||
骨疏康(%) | 51.56 | 50.12 | 54.55 | 56.49 |
荷丹片(%) | 81.83 | 82.31 | 80.77 | 80.52 |
脑血疏口服液(%) | 76.66 | 77.03 | 77.62 | 77.89 |
心可舒片(%) | 86.58 | 88.03 | 85.31 | 84.45 |
其他主营业务(%) | - | - | - | - |
其他(%) | 55.56 | 56.46 | 55.28 | - |
收入构成(%) | ||||
骨疏康(%) | 20.59 | 19.38 | 19.63 | 19.05 |
荷丹片(%) | 11.99 | 12.55 | 12.03 | 11.06 |
脑血疏口服液(%) | 12.91 | 14.47 | 13.23 | 12.99 |
心可舒片(%) | 44.59 | 44.91 | 47.00 | 42.42 |
其他主营业务(%) | - | - | - | 7.24 |
其他(%) | 9.93 | 8.69 | 8.10 | 7.24 |
毛利构成(%) | ||||
骨疏康(%) | 14.26 | 12.84 | 14.23 | 16.40 |
荷丹片(%) | 13.18 | 13.66 | 12.91 | 13.58 |
脑血疏口服液(%) | 13.30 | 14.73 | 13.65 | 15.42 |
心可舒片(%) | 51.86 | 52.27 | 53.27 | 54.60 |
其他主营业务(%) | - | - | - | 0.00 |
其他(%) | 7.41 | 6.49 | 5.95 | 0.00 |